• InfoTell

    We're technologically informed, and we would love to take you along.

    Monday, 15 January 2018

    GV co-leads $27.1M Series A in Oxford Uni life sciences spinout Vaccitech

    16:37 0
     Leaning on its in-house life sciences expertise GV has backed another biotech startup in the UK, co-leading a £20 million ($27.1M) Series A in Oxford University spinout Vaccitech, which is developing a universal flu vaccine. Read More
    Posted by at Edit
    Labels:

    About Unknown

    author image

    No comments:

    Post a Comment